Biologics Safety Testing Market by Product (Instruments, Consumables), Tests (Endotoxin, Sterility, Bioburden, Cell Line Authentication) & Application (Blood Products, Stem Cells, Tissue) - Global Forecast to 2019 Biologics Safety Testing Market is often more complex and requires more specialized evaluations than for small molecule drugs Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=34624144 Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=34624144 Inquiry for more details @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=34624144 Biotechnology has gone through a lot of changes over the years. There is a shift from pharmaceuticals to biopharmaceuticals-based treatment. To capture on the trend, many biotechnology enterprises were established and are continuously increasing in numbers. In the year 2006, the total biotechnology companies were 1,452 in the U.S. and increased by 17% to reach 1,699 in the year 2009. Biologics safety testing is an important step in the launch of new products.
In this report, the global biologic safety testing market is segmented based on product, type of tests, application, and geography. The products segments included in the report are instruments and consumables. Based on types of test this market is categorized into cell line authentication and characterization test, endotoxin testing, LAL test, sterility testing, bioburden testing, residual host contaminant detection test, and adventitious agent detection test. The application segments included in the report are blood and blood products (including serum), tissue and tissue product, cellular and gene therapy product, vaccines and therapeutics and stem cell products. Based on
geography the biologics safety testing market is segmented into North America, Europe, Asia and Rest of the World (RoW). Biologics are products manufactured in or extracted from biological sources. They are extracted from living organisms, and may involve the use of by recombinant DNA technology. Over the past five decades, uniform protocols have been developed for safety and toxicity testing of small molecules. On the other hand, biologics have unique set of properties that are not usually present in small molecules. As such, the safety testing of biologics is more difficult and requires more specialized evaluation than for small molecule drugs. The top leaders in biologic safety testing market include Sigma Aldrich (U.S.), Charles River Laboratories (U.S.), Thermo Fisher Scientific (U.S.), SGS Group (Switzerland), Lonza Group (Switzerland), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.) and others. More Details: http://www.marketsandmarkets.com/Market-Reports/biologics-safety-testing-market34624144.html